News updates
-
19 DEC
Sudden Sensorineural Hearing Loss and COVID-19 vaccines
Until January 10th 2023, the Netherlands Pharmacovigilance Centre Lareb received 109 reports of Sudden Sensorineural Hearing Loss (SSN...
-
08 DEC
Side effects of Tea Tree Oil
The World Health Organization (WHO) received 159 reports of complaints associated with the use of tea tree oil products. Skin complaints such as rash, hypersens...
-
15 NOV
Themes in the course of Adverse Drug Reactions from a patient perspective
Pharmacovigilance centre Lareb has published a study structuring themes in the course of adverse drug reactions (ADRs...
-
14 NOV
Allergic reaction after meningococcal vaccination Nimenrix
The meningococcal ACWY vaccine Nimenrix rarely causes an allergic reaction, as reported to Lareb. Acute allergic reactions are often...
-
06 NOV
Start of the international MedSafetyWeek 2023
Today, the MedSafetyWeek starts. The MedSafetyWeek is an international (social) media campaign focussing on raising awareness of reporting possib...
-
27 OCT
Results from two vaccine cohort event monitoring studies on Influenza vaccines and COVID-19 vaccines
Pharmacovigilance centre Lareb has published results from two vaccine cohort event monitor...
-
27 OCT
Hyperkalemia with fatal outcome during (liposomal) amphotericin B treatment
In rare cases, intravenous administration of (liposomal) amphotericin B treatment can cause severe, difficult to tr...
-
12 SEP
Liver toxicity associated with products containing Ashwagandha
Pharmacovigilance centre Lareb received four reports of liver toxicity in people who used products containing Ashwagandha. These...
-
08 SEP
COVID-vaccination prior to or during pregnancy is not associated with an increased risk of preterm labor
Moeders van Morgen Lareb (the Dutch Pregnancy Drug Register) demonstrated that COVID-...